Search Results : HIV

604 interactions found:

Novel Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
intraflagellar transport 172
Name2
DnaJ heat shock protein family (Hsp40) member C27
Pathway 1
  • Hedgehog 'off' state
  • Intraflagellar transport
  • Intraflagellar transport
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
tubulin alpha 8
Name2
chaperonin containing TCP1 subunit 8 like 2
Pathway 1
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Gap junction assembly
  • MHC class II antigen presentation
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • Recruitment of NuMA to mitotic centrosomes
  • Formation of tubulin folding intermediates by CCT/TriC
  • Post-chaperonin tubulin folding pathway
  • Recycling pathway of L1
  • Recycling pathway of L1
  • Cargo trafficking to the periciliary membrane
  • RHO GTPases activate IQGAPs
  • RHO GTPases Activate Formins
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
  • COPI-independent Golgi-to-ER retrograde traffic
  • Mitotic Prometaphase
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • Carboxyterminal post-translational modifications of tubulin
  • Carboxyterminal post-translational modifications of tubulin
  • HCMV Early Events
  • Assembly and cell surface presentation of NMDA receptors
  • Activation of AMPK downstream of NMDARs
  • Aggrephagy
  • Aggrephagy
  • EML4 and NUDC in mitotic spindle formation
  • Sealing of the nuclear envelope (NE) by ESCRT-III
  • Kinesins
  • PKR-mediated signaling
Pathway 2
Drugs 1
  • Epothilone D
  • Patupilone
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
uracil DNA glycosylase
Name2
keratocan
Pathway 1
Pathway 2
  • Keratan sulfate biosynthesis
  • Keratan sulfate degradation
  • Defective CHST6 causes MCDC1
  • Defective ST3GAL3 causes MCT12 and EIEE15
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
Drugs 1
  • 4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID
  • 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE
  • 3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid
Drugs 2
Diseases 1
  • Hyper IgM syndromes, autosomal recessive type, including the following three diseases: Activation-induced cytidine deaminase (AICD) defect; Uracil nucleotide glycoside glycosylase (UNG) defect; Immunodeficiency with hyper-IgM type 3
Diseases 2
  • Cornea plana congenita
Novel
Novel
Symbols
Name 1
ferredoxin 1
Name2
contactin 5
Pathway 1
  • Mitochondrial iron-sulfur cluster biogenesis
  • Pregnenolone biosynthesis
  • Endogenous sterols
  • Electron transport from NADPH to Ferredoxin
  • Defective CYP11A1 causes AICSR
  • Protein lipoylation
Pathway 2
  • Post-translational modification: synthesis of GPI-anchored proteins
Drugs 1
  • Mitotane
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
HIV-1 Tat specific factor 1
Name2
THAP domain containing 1
Pathway 1
  • mRNA Splicing - Major Pathway
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
N-deacetylase and N-sulfotransferase 1
Name2
ADAM metallopeptidase domain 18
Pathway 1
  • HS-GAG biosynthesis
Pathway 2
Drugs 1
  • Adenosine 3',5'-diphosphate
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
sortilin related VPS10 domain containing receptor 3
Name2
acyl-CoA synthetase medium chain family member 6
Pathway 1
Pathway 2
  • Beta oxidation of butanoyl-CoA to acetyl-CoA
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
N-acetyltransferase 1
Name2
CUB and Sushi multiple domains 1
Pathway 1
  • Acetylation
  • Paracetamol ADME
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
NME/NM23 family member 8
Name2
succinyl-CoA:glutarate-CoA transferase
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
  • Primary ciliary dyskinesia, including: Primary ciliary dyskinesia; Kartagener syndrome
Diseases 2
Novel
Novel
Name 1
arrestin domain containing 4
Name2
threonyl-tRNA synthetase 3
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
taspase 1
Name2
mono-ADP ribosylhydrolase 2
Pathway 1
  • Formation of WDR5-containing histone-modifying complexes
  • Formation of WDR5-containing histone-modifying complexes
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
tolloid like 2
Name2
heparanase 2 (inactive)
Pathway 1
  • Degradation of the extracellular matrix
  • Collagen biosynthesis and modifying enzymes
  • Anchoring fibril formation
  • Crosslinking of collagen fibrils
Pathway 2
  • HS-GAG degradation
Drugs 1
  • Methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy)phosphoryl}-L-alanyl-L-prolinate
Drugs 2
Diseases 1
Diseases 2
  • Urofacial syndrome
Novel
Novel
Name 1
UDP glucuronosyltransferase family 1 member A3
Name2
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
Pathway 1
  • Glucuronidation
  • NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
  • Aspirin ADME
  • Atorvastatin ADME
  • Prednisone ADME
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
laeverin
Name2
DTW motif tRNA-uridine aminocarboxypropyltransferase 2
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
contactin 6
Name2
contactin 4
Pathway 1
  • CHL1 interactions
Pathway 2
  • Post-translational modification: synthesis of GPI-anchored proteins
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
nuclear cap binding protein subunit 1
Name2
nuclear cap binding protein subunit 2
Pathway 1
  • SLBP independent Processing of Histone Pre-mRNAs
  • Formation of RNA Pol II elongation complex
  • Formation of the Early Elongation Complex
  • Transport of the SLBP independent Mature mRNA
  • Transport of the SLBP Dependant Mature mRNA
  • Transport of Mature mRNA Derived from an Intronless Transcript
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • snRNP Assembly
  • RNA Polymerase II Pre-transcription Events
  • FGFR2 alternative splicing
  • RNA polymerase II transcribes snRNA genes
  • mRNA Capping
  • mRNA Splicing - Major Pathway
  • mRNA Splicing - Minor Pathway
  • mRNA 3'-end processing
  • Processing of Capped Intron-Containing Pre-mRNA
  • RNA Polymerase II Transcription Termination
  • SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
  • Processing of Intronless Pre-mRNAs
  • Signaling by FGFR2 IIIa TM
  • Regulation of expression of SLITs and ROBOs
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Nuclear RNA decay
Pathway 2
  • SLBP independent Processing of Histone Pre-mRNAs
  • Formation of RNA Pol II elongation complex
  • Formation of the Early Elongation Complex
  • Transport of the SLBP independent Mature mRNA
  • Transport of the SLBP Dependant Mature mRNA
  • Transport of Mature mRNA Derived from an Intronless Transcript
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • snRNP Assembly
  • RNA Polymerase II Pre-transcription Events
  • FGFR2 alternative splicing
  • RNA polymerase II transcribes snRNA genes
  • mRNA Capping
  • mRNA Splicing - Major Pathway
  • mRNA Splicing - Minor Pathway
  • mRNA 3'-end processing
  • Processing of Capped Intron-Containing Pre-mRNA
  • RNA Polymerase II Transcription Termination
  • SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
  • Processing of Intronless Pre-mRNAs
  • Signaling by FGFR2 IIIa TM
  • Regulation of expression of SLITs and ROBOs
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Nuclear RNA decay
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
nucleoporin 93
Name2
nucleoporin 205
Pathway 1
  • ISG15 antiviral mechanism
  • Transport of the SLBP independent Mature mRNA
  • Transport of the SLBP Dependant Mature mRNA
  • Transport of Mature mRNA Derived from an Intronless Transcript
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • Rev-mediated nuclear export of HIV RNA
  • Transport of Ribonucleoproteins into the Host Nucleus
  • NS1 Mediated Effects on Host Pathways
  • Viral Messenger RNA Synthesis
  • NEP/NS2 Interacts with the Cellular Export Machinery
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Nuclear import of Rev protein
  • Vpr-mediated nuclear import of PICs
  • IPs transport between nucleus and cytosol
  • IP3 and IP4 transport between cytosol and nucleus
  • IP6 and IP7 transport between cytosol and nucleus
  • snRNP Assembly
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of ubiquitinylation proteins
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of HSF1-mediated heat shock response
  • SUMOylation of SUMOylation proteins
  • SUMOylation of chromatin organization proteins
  • SUMOylation of RNA binding proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA replication proteins
  • Transcriptional regulation by small RNAs
  • Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
  • tRNA processing in the nucleus
  • HCMV Early Events
  • HCMV Late Events
  • Postmitotic nuclear pore complex (NPC) reformation
  • Postmitotic nuclear pore complex (NPC) reformation
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
Pathway 2
  • ISG15 antiviral mechanism
  • Transport of the SLBP independent Mature mRNA
  • Transport of the SLBP Dependant Mature mRNA
  • Transport of Mature mRNA Derived from an Intronless Transcript
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • Rev-mediated nuclear export of HIV RNA
  • Transport of Ribonucleoproteins into the Host Nucleus
  • NS1 Mediated Effects on Host Pathways
  • Viral Messenger RNA Synthesis
  • NEP/NS2 Interacts with the Cellular Export Machinery
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Nuclear import of Rev protein
  • Vpr-mediated nuclear import of PICs
  • IPs transport between nucleus and cytosol
  • IP3 and IP4 transport between cytosol and nucleus
  • IP6 and IP7 transport between cytosol and nucleus
  • snRNP Assembly
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of ubiquitinylation proteins
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of HSF1-mediated heat shock response
  • SUMOylation of SUMOylation proteins
  • SUMOylation of chromatin organization proteins
  • SUMOylation of RNA binding proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA replication proteins
  • Transcriptional regulation by small RNAs
  • Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
  • tRNA processing in the nucleus
  • HCMV Early Events
  • HCMV Late Events
  • Postmitotic nuclear pore complex (NPC) reformation
  • Postmitotic nuclear pore complex (NPC) reformation
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
filamin C
Name2
sarcoglycan delta
Pathway 1
  • Cell-extracellular matrix interactions
Pathway 2
  • Formation of the dystrophin-glycoprotein complex (DGC)
  • Formation of the dystrophin-glycoprotein complex (DGC)
Drugs 1
Drugs 2
Diseases 1
  • Myofibrillar myopathies (MFM), including: Desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Myotilinopathy (MFM3); Zaspopathy (MFM4); Filaminopathy (MFM5); Bag3opathy
Diseases 2
  • Dilated cardiomyopathy (DCM)
  • Limb-girdle muscular dystrophy (LGMD)
  • Sarcoglycanopathies, including: Limb-girdle muscular dystrophy (LGMD) 2C; Limb-girdle muscular dystrophy (LGMD) 2D; Limb-girdle muscular dystrophy (LGMD) 2E; Limb-girdle muscular dystrophy (LGMD) 2F
Novel
Novel
Name 1
filamin C
Name2
ribosomal protein S6 kinase A2
Pathway 1
  • Cell-extracellular matrix interactions
Pathway 2
  • ERK/MAPK targets
  • CREB phosphorylation
  • Senescence-Associated Secretory Phenotype (SASP)
  • Senescence-Associated Secretory Phenotype (SASP)
  • Recycling pathway of L1
  • CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling
  • RSK activation
  • RSK activation
  • Gastrin-CREB signalling pathway via PKC and MAPK
Drugs 1
Drugs 2
Diseases 1
  • Myofibrillar myopathies (MFM), including: Desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Myotilinopathy (MFM3); Zaspopathy (MFM4); Filaminopathy (MFM5); Bag3opathy
Diseases 2
Novel
Novel
Symbols
Name 1
filamin C
Name2
xin actin binding repeat containing 2
Pathway 1
  • Cell-extracellular matrix interactions
Pathway 2
  • Sensory processing of sound by inner hair cells of the cochlea
  • Sensory processing of sound by outer hair cells of the cochlea
Drugs 1
Drugs 2
Diseases 1
  • Myofibrillar myopathies (MFM), including: Desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Myotilinopathy (MFM3); Zaspopathy (MFM4); Filaminopathy (MFM5); Bag3opathy
Diseases 2
Novel
Name 1
intraflagellar transport 172
Name2
DnaJ heat shock protein family (Hsp40) member C27
Pathway 1
  • Hedgehog 'off' state
  • Intraflagellar transport
  • Intraflagellar transport
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
tubulin alpha 8
Name2
chaperonin containing TCP1 subunit 8 like 2
Pathway 1
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Gap junction assembly
  • MHC class II antigen presentation
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • Recruitment of NuMA to mitotic centrosomes
  • Formation of tubulin folding intermediates by CCT/TriC
  • Post-chaperonin tubulin folding pathway
  • Recycling pathway of L1
  • Recycling pathway of L1
  • Cargo trafficking to the periciliary membrane
  • RHO GTPases activate IQGAPs
  • RHO GTPases Activate Formins
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
  • COPI-independent Golgi-to-ER retrograde traffic
  • Mitotic Prometaphase
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • Carboxyterminal post-translational modifications of tubulin
  • Carboxyterminal post-translational modifications of tubulin
  • HCMV Early Events
  • Assembly and cell surface presentation of NMDA receptors
  • Activation of AMPK downstream of NMDARs
  • Aggrephagy
  • Aggrephagy
  • EML4 and NUDC in mitotic spindle formation
  • Sealing of the nuclear envelope (NE) by ESCRT-III
  • Kinesins
  • PKR-mediated signaling
Pathway 2
Drugs 1
  • Epothilone D
  • Patupilone
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
uracil DNA glycosylase
Name2
keratocan
Pathway 1
Pathway 2
  • Keratan sulfate biosynthesis
  • Keratan sulfate degradation
  • Defective CHST6 causes MCDC1
  • Defective ST3GAL3 causes MCT12 and EIEE15
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
Drugs 1
  • 4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID
  • 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE
  • 3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid
Drugs 2
Diseases 1
  • Hyper IgM syndromes, autosomal recessive type, including the following three diseases: Activation-induced cytidine deaminase (AICD) defect; Uracil nucleotide glycoside glycosylase (UNG) defect; Immunodeficiency with hyper-IgM type 3
Diseases 2
  • Cornea plana congenita
Novel
Symbols
Name 1
ferredoxin 1
Name2
contactin 5
Pathway 1
  • Mitochondrial iron-sulfur cluster biogenesis
  • Pregnenolone biosynthesis
  • Endogenous sterols
  • Electron transport from NADPH to Ferredoxin
  • Defective CYP11A1 causes AICSR
  • Protein lipoylation
Pathway 2
  • Post-translational modification: synthesis of GPI-anchored proteins
Drugs 1
  • Mitotane
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
HIV-1 Tat specific factor 1
Name2
THAP domain containing 1
Pathway 1
  • mRNA Splicing - Major Pathway
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
N-deacetylase and N-sulfotransferase 1
Name2
ADAM metallopeptidase domain 18
Pathway 1
  • HS-GAG biosynthesis
Pathway 2
Drugs 1
  • Adenosine 3',5'-diphosphate
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
sortilin related VPS10 domain containing receptor 3
Name2
acyl-CoA synthetase medium chain family member 6
Pathway 1
Pathway 2
  • Beta oxidation of butanoyl-CoA to acetyl-CoA
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
N-acetyltransferase 1
Name2
CUB and Sushi multiple domains 1
Pathway 1
  • Acetylation
  • Paracetamol ADME
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
NME/NM23 family member 8
Name2
succinyl-CoA:glutarate-CoA transferase
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
  • Primary ciliary dyskinesia, including: Primary ciliary dyskinesia; Kartagener syndrome
Diseases 2
Novel
Name 1
arrestin domain containing 4
Name2
threonyl-tRNA synthetase 3
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
taspase 1
Name2
mono-ADP ribosylhydrolase 2
Pathway 1
  • Formation of WDR5-containing histone-modifying complexes
  • Formation of WDR5-containing histone-modifying complexes
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
tolloid like 2
Name2
heparanase 2 (inactive)
Pathway 1
  • Degradation of the extracellular matrix
  • Collagen biosynthesis and modifying enzymes
  • Anchoring fibril formation
  • Crosslinking of collagen fibrils
Pathway 2
  • HS-GAG degradation
Drugs 1
  • Methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy)phosphoryl}-L-alanyl-L-prolinate
Drugs 2
Diseases 1
Diseases 2
  • Urofacial syndrome
Novel
Name 1
UDP glucuronosyltransferase family 1 member A3
Name2
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
Pathway 1
  • Glucuronidation
  • NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
  • Aspirin ADME
  • Atorvastatin ADME
  • Prednisone ADME
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
laeverin
Name2
DTW motif tRNA-uridine aminocarboxypropyltransferase 2
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
contactin 6
Name2
contactin 4
Pathway 1
  • CHL1 interactions
Pathway 2
  • Post-translational modification: synthesis of GPI-anchored proteins
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
nuclear cap binding protein subunit 1
Name2
nuclear cap binding protein subunit 2
Pathway 1
  • SLBP independent Processing of Histone Pre-mRNAs
  • Formation of RNA Pol II elongation complex
  • Formation of the Early Elongation Complex
  • Transport of the SLBP independent Mature mRNA
  • Transport of the SLBP Dependant Mature mRNA
  • Transport of Mature mRNA Derived from an Intronless Transcript
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • snRNP Assembly
  • RNA Polymerase II Pre-transcription Events
  • FGFR2 alternative splicing
  • RNA polymerase II transcribes snRNA genes
  • mRNA Capping
  • mRNA Splicing - Major Pathway
  • mRNA Splicing - Minor Pathway
  • mRNA 3'-end processing
  • Processing of Capped Intron-Containing Pre-mRNA
  • RNA Polymerase II Transcription Termination
  • SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
  • Processing of Intronless Pre-mRNAs
  • Signaling by FGFR2 IIIa TM
  • Regulation of expression of SLITs and ROBOs
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Nuclear RNA decay
Pathway 2
  • SLBP independent Processing of Histone Pre-mRNAs
  • Formation of RNA Pol II elongation complex
  • Formation of the Early Elongation Complex
  • Transport of the SLBP independent Mature mRNA
  • Transport of the SLBP Dependant Mature mRNA
  • Transport of Mature mRNA Derived from an Intronless Transcript
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • snRNP Assembly
  • RNA Polymerase II Pre-transcription Events
  • FGFR2 alternative splicing
  • RNA polymerase II transcribes snRNA genes
  • mRNA Capping
  • mRNA Splicing - Major Pathway
  • mRNA Splicing - Minor Pathway
  • mRNA 3'-end processing
  • Processing of Capped Intron-Containing Pre-mRNA
  • RNA Polymerase II Transcription Termination
  • SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
  • Processing of Intronless Pre-mRNAs
  • Signaling by FGFR2 IIIa TM
  • Regulation of expression of SLITs and ROBOs
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Nuclear RNA decay
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
nucleoporin 93
Name2
nucleoporin 205
Pathway 1
  • ISG15 antiviral mechanism
  • Transport of the SLBP independent Mature mRNA
  • Transport of the SLBP Dependant Mature mRNA
  • Transport of Mature mRNA Derived from an Intronless Transcript
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • Rev-mediated nuclear export of HIV RNA
  • Transport of Ribonucleoproteins into the Host Nucleus
  • NS1 Mediated Effects on Host Pathways
  • Viral Messenger RNA Synthesis
  • NEP/NS2 Interacts with the Cellular Export Machinery
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Nuclear import of Rev protein
  • Vpr-mediated nuclear import of PICs
  • IPs transport between nucleus and cytosol
  • IP3 and IP4 transport between cytosol and nucleus
  • IP6 and IP7 transport between cytosol and nucleus
  • snRNP Assembly
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of ubiquitinylation proteins
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of HSF1-mediated heat shock response
  • SUMOylation of SUMOylation proteins
  • SUMOylation of chromatin organization proteins
  • SUMOylation of RNA binding proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA replication proteins
  • Transcriptional regulation by small RNAs
  • Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
  • tRNA processing in the nucleus
  • HCMV Early Events
  • HCMV Late Events
  • Postmitotic nuclear pore complex (NPC) reformation
  • Postmitotic nuclear pore complex (NPC) reformation
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
Pathway 2
  • ISG15 antiviral mechanism
  • Transport of the SLBP independent Mature mRNA
  • Transport of the SLBP Dependant Mature mRNA
  • Transport of Mature mRNA Derived from an Intronless Transcript
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • Rev-mediated nuclear export of HIV RNA
  • Transport of Ribonucleoproteins into the Host Nucleus
  • NS1 Mediated Effects on Host Pathways
  • Viral Messenger RNA Synthesis
  • NEP/NS2 Interacts with the Cellular Export Machinery
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Nuclear import of Rev protein
  • Vpr-mediated nuclear import of PICs
  • IPs transport between nucleus and cytosol
  • IP3 and IP4 transport between cytosol and nucleus
  • IP6 and IP7 transport between cytosol and nucleus
  • snRNP Assembly
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of ubiquitinylation proteins
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of HSF1-mediated heat shock response
  • SUMOylation of SUMOylation proteins
  • SUMOylation of chromatin organization proteins
  • SUMOylation of RNA binding proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA replication proteins
  • Transcriptional regulation by small RNAs
  • Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
  • tRNA processing in the nucleus
  • HCMV Early Events
  • HCMV Late Events
  • Postmitotic nuclear pore complex (NPC) reformation
  • Postmitotic nuclear pore complex (NPC) reformation
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
filamin C
Name2
sarcoglycan delta
Pathway 1
  • Cell-extracellular matrix interactions
Pathway 2
  • Formation of the dystrophin-glycoprotein complex (DGC)
  • Formation of the dystrophin-glycoprotein complex (DGC)
Drugs 1
Drugs 2
Diseases 1
  • Myofibrillar myopathies (MFM), including: Desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Myotilinopathy (MFM3); Zaspopathy (MFM4); Filaminopathy (MFM5); Bag3opathy
Diseases 2
  • Dilated cardiomyopathy (DCM)
  • Limb-girdle muscular dystrophy (LGMD)
  • Sarcoglycanopathies, including: Limb-girdle muscular dystrophy (LGMD) 2C; Limb-girdle muscular dystrophy (LGMD) 2D; Limb-girdle muscular dystrophy (LGMD) 2E; Limb-girdle muscular dystrophy (LGMD) 2F
Novel
Name 1
filamin C
Name2
ribosomal protein S6 kinase A2
Pathway 1
  • Cell-extracellular matrix interactions
Pathway 2
  • ERK/MAPK targets
  • CREB phosphorylation
  • Senescence-Associated Secretory Phenotype (SASP)
  • Senescence-Associated Secretory Phenotype (SASP)
  • Recycling pathway of L1
  • CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling
  • RSK activation
  • RSK activation
  • Gastrin-CREB signalling pathway via PKC and MAPK
Drugs 1
Drugs 2
Diseases 1
  • Myofibrillar myopathies (MFM), including: Desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Myotilinopathy (MFM3); Zaspopathy (MFM4); Filaminopathy (MFM5); Bag3opathy
Diseases 2
Novel
Symbols
Name 1
filamin C
Name2
xin actin binding repeat containing 2
Pathway 1
  • Cell-extracellular matrix interactions
Pathway 2
  • Sensory processing of sound by inner hair cells of the cochlea
  • Sensory processing of sound by outer hair cells of the cochlea
Drugs 1
Drugs 2
Diseases 1
  • Myofibrillar myopathies (MFM), including: Desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Myotilinopathy (MFM3); Zaspopathy (MFM4); Filaminopathy (MFM5); Bag3opathy
Diseases 2

Page 2 out of 31 pages

© Madhavi K. Ganapathiraju 2012-2025